China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

China's biotechnology sector is experiencing notable growth, with the ChinaAMC Hang Seng Biotech ETF, tracking the Hang Seng ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

"China's biotechnology sector thrives on a dual engine ... "China's biopharmaceutical market is rapidly evolving, with significant growth and a strong focus on innovation." ...

Overall, this saw China-based biotech firms increase their market ... However, if the Chinese biotech sector is going to continue its growth trajectory, certain other aspects beyond investment ...

The "China Biotechnology Directory 2025" has been added to ResearchAndMarkets.com's offering. The Chinese biotechnology industry has increased with high annual average growth rates over the last ...

Biotech stock Zai Lab slipped as investors digested ... It serves patients in China, the U.S. and Europe. The China-based company has expanded its presence and now has three offices in the U.S ...

Joint biotech innovation between China and Japan isn’t just a smart strategy – it’s a high-stakes tech and growth accelerator for both countries. Cross-border partnerships crack open access ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical industry to China. Though we have long stood as the global leader in ...